Friday 6 November 2026 Export EOLS’s income statement to Excel — free account

Evolus, Inc.

EOLS Healthcare Drug Manufacturers Specialty & Generic

Evolus, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $297.2 million, up 11.6% from fiscal 2024.

Revenue: +13.0%
EPS: +21.1%
Free cash flow: +77.7%
Total debt: +7.63%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

6.86 0.06 +0.88%

Follow EOLS

Alert me

Market cap: $448.8M
P/E: 0.0×
Fwd P/E: −14.9×
Dividend yield: —
F-score: 3/9
Altman Z: −1.87
Beneish M: −2.59
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	3	3	4
ROE Full definition →		587.36%	245.43%	138.57%	93.47%
ROA Full definition →		(22.53%)	(20.01%)	(14.40%)	(12.38%)
ROIC Full definition →		(29.51%)	(19.54%)	(14.47%)	(12.60%)
Return on Tangible Assets Full definition →		(70.76%)	(56.96%)	(46.48%)	(48.46%)
Average Days of Receivables Full definition →		67.18	63.16	71.95	67.60
Free Cash Flow per Share Full definition →		(0.79)	(0.69)	(0.33)	(0.13)
Free Cash Flow Full definition →		(50.72)	(44.87)	(21.90)	(8.82)
Capital Expenditures Full definition →		(8.45)	(8.28)	(6.51)	(6.17)
Other line items
Cash ROIC Full definition →		(28.68%)	(25.29%)	(12.80%)	(5.48%)
Accounts Receivable Turnover Full definition →		5.81	6.06	5.75	5.88
Accounts Payable Turnover Full definition →		6.14	5.74	3.11	2.01
Inventory Turnover Full definition →		5.12	5.88	3.13	1.89
Average Days of Payables Full definition →		85.21	69.58	154.21	287.51
Days of Inventory on Hand Full definition →		98.35	88.35	141.79	276.22
Tax Rate Full definition →		0.01	0.02	0.02	0.03
Research and Development Expense of Revenue Full definition →		3.22%	3.18%	3.05%	2.94%
Selling, General and Administrative Expense of Revenue Full definition →		74.29%	71.61%	68.41%	66.55%
Share Based Compensation of Revenue Full definition →		6.96%	6.59%	6.64%	6.60%
Interest Coverage Full definition →		(1.66)	(1.26)	(1.15)	(0.95)
Operating CF/Net income Full definition →		0.82	0.84	0.45	0.09
Depreciation/Fixed assets Full definition →		1.87	2.05	2.32	2.57
Capex/Depreciation Full definition →		(0.84)	(0.76)	(0.56)	(0.49)
Revenue per Share Full definition →		4.61	4.63	4.80	4.93
Operating CF per Share Full definition →		(0.66)	(0.56)	(0.23)	(0.04)
Capex per Share Full definition →		(0.13)	(0.13)	(0.10)	(0.09)
Capex to Sales Full definition →		0.03	0.03	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly